Erythropoiesis Stimulating Agents (ESA)
Showing 1 - 25 of 7,131
End Stage Renal Disease Trial in Kaohsiung (AI (model))
Completed
- End Stage Renal Disease
- AI (model)
-
Kaohsiung, TW, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Aug 31, 2021
End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)
Recruiting
- End Stage Renal Disease on Dialysis
- novel artificial intelligence assisted platform
-
Kaohsiung,, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Oct 5, 2021
MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)
Recruiting
- Myelodysplastic Syndromes (MDS)
- Sodium Valproate, Bezafibrate, Medroxyprogesterone
- Danazol
-
Dudley, England, United Kingdom
- +7 more
Aug 12, 2022
Erythropoiesis Stimulating Agents for Anemia Management in
Completed
- Anemia of Chronic Kidney Disease
- +2 more
-
Giza, Egyptthe Memorial Souad Kafafi University Hospital
Jan 24, 2023
Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis
Not yet recruiting
- Erythropoietin Resistant Anemia (EPO Resistant Anemia)
- (no location specified)
Sep 22, 2023
Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)
Suspended
- Anemia of Chronic Kidney Disease
-
Hackensack, New JerseyResearch Site
Aug 23, 2022
MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)
Recruiting
- Myelodysplastic Syndromes
- Canakinumab Injection
- Darbepoetin Alfa
-
Tampa, FloridaMoffitt Cancer Center
Nov 21, 2022
Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)
Recruiting
- Anemia
- Ferric Derisomaltose Injection
- Darbepoetin Alfa Injection
-
Anyang-si, Korea, Republic ofHallym University Medical Center
Mar 13, 2023
MDS Trial in Worldwide (Talacotuzumab, Daratumumab)
Completed
- Myelodysplastic Syndromes
-
Saint Louis, Missouri
- +20 more
Dec 28, 2022
Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)
Recruiting
- Anemia in Dialysis-dependent CKD Patients
-
Alexandria, EgyptAlexandria University
Oct 29, 2023
Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)
Not yet recruiting
- Anemia, Sickle Cell
- Sickle Cell Disease
- Hydroxyurea
- Epoetin Alfa
-
Pittsburgh, Pennsylvania
- +1 more
Aug 4, 2022
Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,
Completed
- Hyperphosphatemia
- +2 more
- Ferric Citrate 1 gram Oral Tablet
- Standard of care phosphate-lowering therapy
-
Anchorage, Alaska
- +12 more
Nov 3, 2022
Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)
Recruiting
- Anemia
- Paricalcitol
- +2 more
-
Palma de Mallorca, Islas Baleares, SpainSon Espases University Hospital
Mar 3, 2021
Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)
Terminated
- Anemia
- Dialysis-Dependent Chronic Kidney Disease
- vadadustat
- epoetin alfa
-
Bakersfield, California
- +17 more
Feb 2, 2021
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
MDS Trial in Worldwide (Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Los Alamitos, California
- +53 more
Sep 13, 2023
MDS Trial in Beijing (Roxadustat, Luspatercept)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 17, 2023
Chronic Kidney Disease Hyporesponsive Anemia to Erythropoiesis
Completed
- Renal Anemia
- Chronic Kidney Disease
-
Niigata, JapanNiigata University Graduate School of Medicine
Jun 17, 2020
End Stage Renal Disease (ESRD) Trial in Poitiers (Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™)
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™) dialyzer
-
Poitiers, FranceCHU de Poitiers
Jan 12, 2023
Hyperphosphatemia Trial in Los Angeles (Ferric Citrate)
Completed
- Hyperphosphatemia
- Ferric Citrate
-
Los Angeles, CaliforniaKaiser Permanente Los Angeles Medical Center
Jan 3, 2022
Dialysis Trial in Murray (Algorithm model-based Aranesp doses, Standard of care)
Not yet recruiting
- Dialysis
- Algorithm model-based Aranesp doses
- Standard of care
-
Murray, Utah
- +1 more
Jun 27, 2023